CRSP
Price
$40.50
Change
-$0.22 (-0.54%)
Updated
Dec 23, 04:59 PM (EDT)
56 days until earnings call
IMUX
Price
$1.06
Change
+$0.06 (+6.00%)
Updated
Dec 23, 04:59 PM (EDT)
58 days until earnings call
Ad is loading...

CRSP vs IMUX

Header iconCRSP vs IMUX Comparison
Open Charts CRSP vs IMUXBanner chart's image
CRISPR Therapeutics AG
Price$40.50
Change-$0.22 (-0.54%)
Volume$33.1K
CapitalizationN/A
Immunic
Price$1.06
Change+$0.06 (+6.00%)
Volume$19.64K
CapitalizationN/A
CRSP vs IMUX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. IMUX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and IMUX is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (CRSP: $40.48 vs. IMUX: $1.07)
Brand notoriety: CRSP and IMUX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 79% vs. IMUX: 75%
Market capitalization -- CRSP: $3.46B vs. IMUX: $96.38M
CRSP [@Biotechnology] is valued at $3.46B. IMUX’s [@Biotechnology] market capitalization is $96.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileIMUX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • IMUX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMUX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while IMUX’s TA Score has 2 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • IMUX’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than IMUX.

Price Growth

CRSP (@Biotechnology) experienced а -8.50% price change this week, while IMUX (@Biotechnology) price change was -3.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

IMUX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.46B) has a higher market cap than IMUX($96.4M). IMUX YTD gains are higher at: -28.667 vs. CRSP (-35.335). IMUX has higher annual earnings (EBITDA): -95.68M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. IMUX (59.1M). IMUX has less debt than CRSP: IMUX (899K) vs CRSP (228M). CRSP has higher revenues than IMUX: CRSP (200M) vs IMUX (0).
CRSPIMUXCRSP / IMUX
Capitalization3.46B96.4M3,584%
EBITDA-313.08M-95.68M327%
Gain YTD-35.335-28.667123%
P/E RatioN/AN/A-
Revenue200M0-
Total Cash1.94B59.1M3,276%
Total Debt228M899K25,362%
FUNDAMENTALS RATINGS
CRSP vs IMUX: Fundamental Ratings
CRSP
IMUX
OUTLOOK RATING
1..100
5859
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
8485
P/E GROWTH RATING
1..100
83100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMUX's Valuation (35) in the Pharmaceuticals Major industry is in the same range as CRSP (62) in the Biotechnology industry. This means that IMUX’s stock grew similarly to CRSP’s over the last 12 months.

IMUX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CRSP (100) in the Biotechnology industry. This means that IMUX’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (93) in the Biotechnology industry is in the same range as IMUX (99) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to IMUX’s over the last 12 months.

CRSP's Price Growth Rating (84) in the Biotechnology industry is in the same range as IMUX (85) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to IMUX’s over the last 12 months.

CRSP's P/E Growth Rating (83) in the Biotechnology industry is in the same range as IMUX (100) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to IMUX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPIMUX
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 16 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSDVF214.265.66
+2.71%
DSV A S
TIIAY2.490.04
+1.63%
Telecom Italia S.p.A.
UNRG0.04N/A
+0.60%
United Energy Corp.
EZOO0.62N/A
N/A
EZAGOO LTD.
NSANY5.68N/A
N/A
Nissan Motor Co., Ltd.

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.59%
BEAM - CRSP
73%
Closely correlated
-1.07%
PRME - CRSP
62%
Loosely correlated
-3.10%
NTLA - CRSP
62%
Loosely correlated
-0.66%
RXRX - CRSP
60%
Loosely correlated
+15.92%
EDIT - CRSP
59%
Loosely correlated
-4.58%
More

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with NTLA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
+7.00%
NTLA - IMUX
42%
Loosely correlated
-0.66%
PGEN - IMUX
41%
Loosely correlated
-2.16%
VERV - IMUX
41%
Loosely correlated
+2.79%
CRSP - IMUX
40%
Loosely correlated
-0.59%
DNA - IMUX
39%
Loosely correlated
-6.15%
More